Despite the government's ultimatum for disciplinary actions ending on Thursday, thousands of Korean medical residents have yet to return to work. As of Tuesday, a total of 9,267 residents from 100 training hospitals were ordered to return, with 5,976 confirmed to have not complied with the order.Vic
CHA Biotech said it had achieved its highest-ever annual revenue, posting a consolidated revenue of 954 billion won ($798 million) for the year 2023, up 13 percent from the previous year, thanks to strong business performance overseas.Despite the global economic slowdown, CHA Biotech attributed its
Kolon Life Science said it has decided to appeal to the Supreme Court against the revocation of the manufacturing and sales license for its knee osteoarthritis cell and gene therapy, Invossa-K Inj.This move comes after the company faced defeats in both the district and appellate courts.Most recently
Severance Hospital said that Professor Kuh Sung-uk at the Department of Neurosurgery, who also teaches at Yonsei University's College of Medicine, was honored with the grand prize at the 8th Medical Device Industry Awards Ceremony.Professor Kuh also serves as head of external relations at Severance
Celltrion said it has commenced the first shipment of Zymfentra, the world’s first subcutaneous form of infliximab, to the U.S. targeting autoimmune diseases. The company announced that the initial shipment batch was airlifted today to Atlanta, U.S., with plans to complete three shipment phases by e
In the rapidly evolving landscape of healthcare, digital therapeutics (DTx) have emerged as a groundbreaking third generation of treatment, drawing global attention as a promising sector. These software-based interventions, designed to treat diseases and enhance health much like traditional pharmace
Kakao Healthcare said over 50 health regulatory officials, including those from the Ministry of Food and Drug Safety, the WHO, and the U.S. FDA, visited its headquarters on Monday in light of the AI Regulatory and International Symposium 2024 (AIRIS 2024).The event is ongoing at the Shilla Seoul Hot
A Severance Hospital research team has revealed that a hemostatic powder made from plant extracts significantly improves the success rate of initial hemostasis in patients with gastrointestinal bleeding caused by peptic ulcers.Peptic ulcers, which result from the digestive acid eroding the lining of
CG Bio said it has become the largest shareholder in Innosys, a research and manufacturing company focused on orthopedic implants, following the completion of an equity acquisition on Tuesday.The acquisition involved CG Bio finalizing share transfer agreements for a 17.75 percent stake in Innosys an
A research team at CHA Bundang Medical Center has developed a promising solution for male infertility, particularly for patients suffering from Klinefelter syndrome.Klinefelter syndrome, characterized by the presence of an extra X chromosome (XXY instead of the typical XY), is the most common cause
Medytox has encountered a significant setback as the U.S. FDA has declined the biologics license application (BLA) for its innovative non-animal liquid botulinum toxin product, MT10109L, aimed at reducing moderate to severe glabellar (forehead) and lateral canthal (crow's feet) lines.The refusal, da
The Korean government has made a formal proposal to the nation's medical community, urging them to appoint representative members to engage in discussions on critical issues such as the expansion of medical school quotas and the cessation of ongoing collective actions, including strikes and mass res
Samsung Bioepis said that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara, last Sunday. This biosimilar, referencing Janssen's Stelara (ingredient: uste
CKD Bio said it has confirmed the non-inferiority of CKDB-501A, aimed at improving moderate to severe frown lines, compared to Botox through a phase 3 clinical trial's topline results.The analysis of the data revealed that the improvement rate for frown lines when frowning was 80.69 percent (117 out
A new proposal for the expansion of medical school quotas by Professor Shin Young-seok of the Korea University Graduate School of Public Health, the principal researcher who previously provided the basis for the government's plan to increase the number of medical students by 2,000, is drawing signif
GC Cell said that its U.S. affiliate, Artiva Biotherapeutics, has received fast-track designation from the U.S. FDA for their investigational lupus nephritis treatment, AlloNK (development code name: AB-101).The fast track designation is intended to facilitate the development and expedite the review
The Korea Research-based Pharmaceutical Industry Association (KRPIA) announced that it has appointed Bae Kyung-eun, General Manager of Sanofi-Aventis Korea, as the 15th chairperson of the association.This decision was made during the association's board meeting, marking a new chapter in KRPIA's lead
Alteogen, a Kosdaq-listed biotech company, said it has made an amendment to its existing license agreement with the global pharmaceutical company MSD, known as Merck & Co. in the U.S. and Canada.The revised agreement grants MSD exclusive global rights to ALT-B4, a recombinant human hyaluronidase enz
Samsung Bioepis said it has made significant progress with its autoimmune disease treatment biosimilar, SB17, suggesting its potential use across all indications treatable by the original drug, Stelara.Stelara is an interleukin (IL)-12, 23 inhibitor developed by Janssen. It is used to treat inflamma
In a move to combat the rising threat of cardiovascular disease (CVD) in the Asia-Pacific region, Korea Biomedical Review (KBR) has announced its partnership with the APAC CVD Alliance on Thursday. Yang Kyung-cheol, CEO and publisher of KBR, and Dr. Krishna Reddy Nallamalla, CEO of ACCESS Health Int